The agreement on the hysteroscopic diagnosis of septate uterus was found to be poor. Clear definitions are needed to use hysteroscopy as a reliable screening tool for uterine cavity abnormalities.

In conservative surgical treatment of PPH, pelvic vessel embolization and compressive sutures are associated not only with high rates of subsequent fertility but also with placental disorders, intrauterine growth restriction, cesarean delivery, and PPH recurrence.

The duration of endometrial wound healing is different after various hysteroscopic surgeries. It can be clearly observed with postoperative monthly office hysteroscopic examinations.

Cognitive behavior therapy not only restored ovarian function in women with functional hypothalamic amenorrhea (FHA) but it also lowered cortisol levels and improved neuroendocrine and metabolic concomitants of FHA.

Small glutamine-rich tetratricopeptide repeat–containing protein alpha is expressed in human ovarian tissues and has the potential to modulate androgen receptor signaling, but expression levels may not be abnormal in polycystic ovary syndrome.

Rate of ovarian primordial follicle recruitment increases prepubertally then declines again following the onset of puberty, while ovarian follicle activity continues to increase. These changes seem to track with the age of menarche.

Ganglionic cholinergic stimulation produces changes in ovarian release of progesterone, gonadotropin-releasing hormone, noradrenaline, and adrenaline; the ovarian nerve plexus regulates these mechanisms through the release of different neurotransmitters.

Differences in gene expression in individual second polar bodies may be potential markers for minimally invasive testing of embryo developmental competence.

Treatment of mice with G-CSF with or without SCF protects ovarian follicle pool and extends time to premature ovarian insufficiency in mice treated with alkylating chemotherapy.

Among 62 women with diminished ovarian reserve, self-esteem significantly predicted fertility distress both directly and indirectly through emotional reactions to potentially being a fragile X premutation carrier.

Data from a large U.S. case-control study of ovarian tumors revealed no significant association between fertility drug use and the risk of developing ovarian tumors among infertile women.

A total of 319 couples seeking fertility treatment spent an average of 125 hours obtaining care. This burden significantly adds to the financial and mental stress of pursuing fertility treatment.

Gonadotropin-releasing hormone agonist and/or an aromatase inhibitor treatment stabilized or improved disease in patients with benign metastasizing leiomyoma; a selective progesterone receptor modulator was associated with improved symptoms despite increasing fibroid size.

Exploratory genetic analysis of functional polymorphisms 5-HTTLPR and rs6295 reveals clinical implications during early pregnancy loss events in recipients undergoing IVF treatments using donated oocytes.

Vitrification of oocytes is a reproducible, safe, and efficient method for fertility preservation in both oncological and nononcological patients, with a rapidly increasing demand and proven efficacy.

Natural killer and T-regulatory cells participate in the pathogenesis of endometriosis; establishing the role of certain chemokines in modulating this response represents a fundamental key to understanding the inflammatory response.

Mitochondrial displacement (D-) loop alterations may constitute an inheritable risk factor for endometriosis. The analysis of D-loop alterations might help to identify patients at high risk for disease outcome.

Immunohistochemical staining for IMP3 is a simple, inexpensive, and sensitive test that can be used as a triage tool to discriminate between preneoplastic atypia and confounding benign conditions.

Multidrug resistance–associated protein 4 expression is augmented in peritoneal endometriotic lesions, where it localizes to glandular epithelial cells and is inhibited by lipoxin A4 in endometriotic epithelial cells in vitro.

Fecundability peaks around age 30 years and then declines, more steeply for nulliparous women. Men have a more modest decline with age. Volitional factors can offset some of the decline.